肺癌治疗相关系统评价或Meta分析的质量评价

Quality evaluation of Chinese literatures on systematic review and Meta-analysis of lung cancer treatment literature

目的:利用AMSTAR、PRISMA两种方法学质量评价工具评估肺癌相关治疗性系统评价或Meta分析文献的质量。方法:电子检索中国期刊全文数据库(CNKI)、维普中文科技期刊全文数据库(VIP)、万方医药期刊全文数据库等数据库,并辅以手工检索,检索时间为2001年1月至2011年12月,分别采用AMSTAR、PRISMA量表评估肺癌治疗相关系统评价的质量,采用SPSS 16.0进行统计分析。结果:最终纳入74篇文献进行质量评价,85.1%方法学质量评价在6分以下,71.6%报告质量评价大多在13分以下。结论:肺癌相关性系统评价或Meta分析在方法学质量和报告质量两方面均普遍较低,需引起重视,进一步改进与提高。

Objective： To evaluate the literature quality of systematic review or Meta-analysis in the treatment of lung cancer based on AMSTAR（a measurement tool to assess systematic reviews） and PRISMA.Methods： Comprehensive literature was retrieved from CNKI,VIP,WANFANG and others databases,as well as hand searching in the treatment of lung cancer.The retrieval time started from January 2001 to December 2011.The quality of systematic review was evaluated by using AMSTAR and PRISMA.The statistical analysis were analyzed by using SPSS 16.0 software.Results： 74 quality evaluation literature were included eventually,85.1% methodological quality evaluation at six points or less,71.6% quality evaluation mostly at 13 points or less.Conclusion： Poor methodological and quality assessment on systematic review or meta-analysis of lung cancer need to be improved and emphasized.